Seven patients who had multiple metastases were treated with adjuvant chemotherapy after the initial surgery; according to the specific conditions, 2 patients with vaginal ESS were treated with chemotherapy and radiation therapy, and 6 patients with ER/PR positive received hormone therapy with or without chemotherapy. This evidence concerns the gene ESR1 and endometrioid stromal sarcoma.